According to Baudax Bio 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.06558. At the end of 2023 the company had a P/S ratio of 11.0.
Year | P/S ratio | Change |
---|---|---|
2023 | 11.0 | 92.49% |
2022 | 5.69 | -66.84% |
2021 | 17.2 | -80.35% |
2020 | 87.4 | |
2019 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |